Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer
International Journal of Drug Delivery Technology · 25.04.2026 · 16 (19s)
DOI: 10.25258/ijddt.16.19s.65 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Malkiet Kaur und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Diclofenac, generally used as a non-steroidal anti-inflammatory drug (NSAID), is effective in treating pain and inflammatory conditions but causes gastrointestinal and renal side effects upon oral administration. This study aims to develop and evaluate a transdermal microemulsion formulation of diclofenac using piperine as a bioenhancer, leading to enhanced drug permeability and therapeutic efficacy.
Methods
Pseudo-ternary phase diagrams were formed by using oleic acid (oil phase), Cremophor RH40 (surfactant), and Transcutol (co-surfactant). Optimized microemulsions were assessed for particle size, zeta potential, in vitro release studies of drug, ex vivo permeation and in vivo studies, including drug pharmacokinetics. Scanning electron microscopy (SEM) studies were carried out to assess skin permeability.
Results
Optimized microemulsions exhibited high clarity (transmittance >90%) and nano-sized droplets (A4: 11.41 nm, B1: 12.16 nm). In vitro studies showed A4 released 60% of the drug in 4 hours, while B1 took 6 hours, indicating both immediate and sustained release potential. Ex vivo studies confirmed enhanced drug permeation, with 80% release from A4-based gel and 76% from B1-based gel in 24 hours. SEM studies revealed an increase in skin porosity in the microemulsion, which may be due to the inclusion of piperine. In vivo studies confirmed sustained plasma drug levels with the piperine-enhanced formulation.
Conclusion
The diclofenac-piperine microemulsion gel demonstrated enhanced transdermal absorption, sustained drug release, and reduced systemic toxicity. It offers a promising alternative to oral diclofenac for safer and more effective pain management.
Zitieren
APA
Kaur, M., Nagpal, M., Saini, B., Singh, T. G., Singh, M., Aggarwal, G., & Dhingra, G. A. (2026). Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer. International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.65
Vancouver
Kaur M, Nagpal M, Saini B, Singh TG, Singh M, Aggarwal G, et al. Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer. International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.65
BibTeX
@article{Kaur2026,
author = {Kaur, Malkiet and Nagpal, Manju and Saini, Balraj and Singh, Thakur Gurjeet and Singh, Manjinder and Aggarwal, Geeta and Dhingra, Gitika Arora},
title = {Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {19s},
doi = {10.25258/ijddt.16.19s.65}
}
EUVIMED